Seoul, Seoul / / October 9, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways Stem cell therapy offers a minimally invasive ...

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

New research found that gene therapy for children with "bubble boy disease," or SCID, was successful in 95% of trial ...

A research team has introduced a novel cancer immunotherapy strategy. This approach involves attaching "fake targets" to ...

Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated ...

A groundbreaking gene therapy has successfully restored immune function in children with ADA-SCID, a severe genetic disorder. Developed by internation ...

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...